Human Reproduction, Vol. 17, No. 12, 3065-3071,
December 2002
© 2002 European Society of Human Reproduction and Embryology
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve
1 Department of Reproductive Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, 2 Department of Internal Medicine and 3 Center of Reproductive Medicine, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
BACKGROUND: Anti-Müllerian hormone (AMH) is produced by the granulosa cells of preantral and small antral follicles and its levels can be assessed in serum. Since the number of ovarian follicles declines with increasing age, AMH levels might be used as a marker for ovarian ageing. Therefore, we studied the relationship between AMH levels and ovarian response during ovarian stimulation for IVF. METHODS: A total of 130 patients undergoing their first IVF treatment cycle using a long protocol with GnRH agonist was prospectively included. Blood withdrawal was performed and the number of antral follicles was assessed by ultrasound on day 3 of a spontaneous cycle. Poor response and the number of oocytes were used as primary outcome measures. In a random subset of 23 patients a GnRH agonist stimulation test was performed to investigate whether a rise in FSH and LH would affect AMH levels. RESULTS: The data of 119 patients were analysed. Serum AMH levels were highly correlated with the number of antral follicles (r = 0.77; P < 0.01) and the number of oocytes retrieved (r = 0.57, P < 0.01). A negative association was found between AMH levels and poor ovarian response (fewer than 4 oocytes or cycle cancellation; OR 0.82, 95% CI 0.75–0.90, P < 0.01). Inclusion of inhibin B and FSH concentrations to AMH in a multivariate model improved the prediction of ovarian response. The post GnRH agonist rise in FSH and LH levels did not influence AMH values. CONCLUSIONS: Poor response in IVF, indicative of a diminished ovarian reserve, is associated with reduced baseline serum AMH concentrations. In line with recent observations it appears that AMH can be used as a marker for ovarian ageing.
Key words: anti-Müllerian hormone/antral follicle count/IVF/ovarian reserve/poor response
4 To whom correspondence should be addressed. E-mail: i.vanrooij{at}azu.nl
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. R. Sowers, A. D. Eyvazzadeh, D. McConnell, M. Yosef, M. L. Jannausch, D. Zhang, S. Harlow, and J. F. Randolph Jr. Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3478 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jayaprakasan, B.K. Campbell, J.F. Hopkisson, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone Hum. Reprod., July 25, 2008; (2008) den282v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Disseldorp, M. J. Faddy, A. P. N. Themmen, F. H. de Jong, P. H. M. Peeters, Y. T. van der Schouw, and F. J. M. Broekmans Relationship of Serum Antimullerian Hormone Concentration to Age at Menopause J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2129 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yding Andersen, M. Rosendahl, and A. G. Byskov Concentration of Anti-Mullerian Hormone and Inhibin-B in Relation to Steroids and Age in Follicular Fluid from Small Antral Human Follicles J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2344 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. de Koning, J. McDonnell, A.P.N. Themmen, F.H. de Jong, R. Homburg, and C.B. Lambalk The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls Hum. Reprod., June 1, 2008; 23(6): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rohr, E.G. Allen, K. Charen, J. Giles, W. He, C. Dominguez, and S.L. Sherman Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study Hum. Reprod., May 1, 2008; 23(5): 1220 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.E.M. Verhagen, D.J. Hendriks, L.F.J.M.M. Bancsi, B.W.J. Mol, and F.J.M. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis Hum. Reprod. Update, March 1, 2008; 14(2): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Lee, C.-H. Liu, C.-C. Huang, Y.-L. Wu, Y.-T. Shih, H.-N. Ho, Y.-S. Yang, and M.-S. Lee Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum. Reprod., January 1, 2008; 23(1): 160 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arbo, D.V. Vetori, M.F. Jimenez, F.M. Freitas, N. Lemos, and J.S. Cunha-Filho Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills Hum. Reprod., December 1, 2007; 22(12): 3192 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Moran, M. Noakes, P. M. Clifton, and R. J. Norman The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3796 - 3802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Nelson, R. W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy Hum. Reprod., September 1, 2007; 22(9): 2414 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Kevenaar, A. P.N. Themmen, F. Rivadeneira, A. G. Uitterlinden, J. S.E. Laven, N. M. van Schoor, P. Lips, H. A.P. Pols, and J. A. Visser A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity Hum. Reprod., September 1, 2007; 22(9): 2382 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J.K. Hehenkamp, N. A. Volkers, F. J.M. Broekmans, F. H. de Jong, A. P.N. Themmen, E. Birnie, J. A. Reekers, and W. M. Ankum Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy Hum. Reprod., July 1, 2007; 22(7): 1996 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, Ch. Gervy, and Y. Englert Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum. Reprod., July 1, 2007; 22(7): 1837 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Barad, A. Weghofer, and N. Gleicher Age-Specific Levels for Basal Follicle-Stimulating Hormone Assessment of Ovarian Function Obstet. Gynecol., June 1, 2007; 109(6): 1404 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Kevenaar, A. P.N. Themmen, J. S.E. Laven, B. Sonntag, S. L. Fong, A. G. Uitterlinden, F. H. de Jong, H. A.P. Pols, M. Simoni, and J. A. Visser Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women Hum. Reprod., June 1, 2007; 22(6): 1547 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fanchin, D. H. Mendez Lozano, N. Frydman, A. Gougeon, N. di Clemente, R. Frydman, and J. Taieb Anti-Mullerian Hormone Concentrations in the Follicular Fluid of the Preovulatory Follicle Are Predictive of the Implantation Potential of the Ensuing Embryo Obtained by in Vitro Fertilization J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1796 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Seifer, D. T. MacLaughlin, and H. S. Cuckle Serum mullerian-inhibiting substance in Down's syndrome pregnancies Hum. Reprod., April 1, 2007; 22(4): 1017 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, S. Xella, and A. Volpe Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Hum. Reprod., March 1, 2007; 22(3): 766 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez, P. Alama, B. Gadea, S.R. Soares, C. Simon, and A. Pellicer Fresh human orthotopic ovarian cortex transplantation: long-term results Hum. Reprod., March 1, 2007; 22(3): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Meduri, N. Massin, J. Guibourdenche, A. Bachelot, O. Fiori, F. Kuttenn, M. Misrahi, and P. Touraine Serum anti-Mullerian hormone expression in women with premature ovarian failure Hum. Reprod., January 1, 2007; 22(1): 117 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maheshwari, P. Fowler, and S. Bhattacharya Assessment of ovarian reserve--should we perform tests of ovarian reserve routinely? Hum. Reprod., November 1, 2006; 21(11): 2729 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Qahtani and N. P. Groome Anti-Mullerian Hormone: Cinderella Finds New Admirers. J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3760 - 3762. [Full Text] [PDF]
|
|
|
|
|
|
W. J. K. Hehenkamp, C. W. N. Looman, A. P. N. Themmen, F. H. de Jong, E. R. te Velde, and F. J. M. Broekmans Anti-Mullerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial Fluctuation J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4057 - 4063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Andersen and A. G. Byskov Estradiol and Regulation of Anti-Mullerian Hormone, Inhibin-A, and Inhibin-B Secretion: Analysis of Small Antral and Preovulatory Human Follicles' Fluid J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4064 - 4069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.A. Anderson, A.P.N. Themmen, A.A. -Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum. Reprod., October 1, 2006; 21(10): 2583 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oktay, O. Oktem, A. Reh, and L. Vahdat Measuring the Impact of Chemotherapy on Fertility in Women With Breast Cancer J. Clin. Oncol., August 20, 2006; 24(24): 4044 - 4046. [Full Text] [PDF]
|
|
|
|
 |
|
 P. G Knight and C. Glister TGF-{beta} superfamily members and ovarian follicle development. Reproduction, August 1, 2006; 132(2): 191 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-Lechner, and G. Tews Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles Hum. Reprod., August 1, 2006; 21(8): 2022 - 2026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Kevenaar, M. F. Meerasahib, P. Kramer, B. M. N. van de Lang-Born, F. H. de Jong, N. P. Groome, A. P. N. Themmen, and J. A. Visser Serum Anti-Mullerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice Endocrinology, July 1, 2006; 147(7): 3228 - 3234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fleming, N. Deshpande, I. Traynor, and R.W.S. Yates Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone Hum. Reprod., June 1, 2006; 21(6): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen Anti-Mullerian hormone: a new marker for ovarian function Reproduction, January 1, 2006; 131(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, D.B. Seifer, D.L. Keefe, and A.S. Blazar Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Hum. Reprod., January 1, 2006; 21(1): 159 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ng, O. S. Tang, C. C. W. Chan, and P. C. Ho Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment Hum. Reprod., November 1, 2005; 20(11): 3147 - 3151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eldar-Geva, A. Ben-Chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E. J. Margalioth Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome Hum. Reprod., November 1, 2005; 20(11): 3178 - 3183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kline, A. Kinney, A. Kelly, M.L. Reuss, and B. Levin Predictors of antral follicle count during the reproductive years Hum. Reprod., August 1, 2005; 20(8): 2179 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lobo Potential Options for Preservation of Fertility in Women N. Engl. J. Med., July 7, 2005; 353(1): 64 - 73. [Full Text] [PDF]
|
|
|
|
|
|
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eldar-Geva, E. J. Margalioth, M. Gal, A. Ben-Chetrit, N. Algur, E. Zylber-Haran, B. Brooks, M. Huerta, and I. M. Spitz Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism Hum. Reprod., July 1, 2005; 20(7): 1814 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J. S. Tapanainen Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome Hum. Reprod., July 1, 2005; 20(7): 1820 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, and P. C. Ho Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment Hum. Reprod., June 1, 2005; 20(6): 1647 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. La Marca, S. Giulini, R. Orvieto, V. De Leo, and A. Volpe Anti-Mullerian hormone concentrations in maternal serum during pregnancy Hum. Reprod., June 1, 2005; 20(6): 1569 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fanchin, J. Taieb, D. H. M. Lozano, B. Ducot, R. Frydman, and J. Bouyer High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status Hum. Reprod., April 1, 2005; 20(4): 923 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment Hum. Reprod., April 1, 2005; 20(4): 915 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iwase, H. Ando, K. Kuno, and S. Mizutani Use of Follicle-Stimulating Hormone Test to Predict Poor Response in In Vitro Fertilization Obstet. Gynecol., March 1, 2005; 105(3): 645 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fanchin, D. H. Mendez Lozano, N. Louafi, N. Achour-Frydman, R. Frydman, and J. Taieb Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation Hum. Reprod., March 1, 2005; 20(3): 747 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. N. Themmen Anti-Mullerian Hormone: Its Role in Follicular Growth Initiation and Survival and as an Ovarian Reserve Marker J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 18 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Hendriks, F.J.M. Broekmans, L.F.J.M.M. Bancsi, F.H. de Jong, C.W.N. Looman, and E.R. te Velde Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve Hum. Reprod., January 1, 2005; 20(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jonard, P. Pigny, L. Jacquesson, C. Demerle-Roux, Y. Robert, and D. Dewailly The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea Hum. Reprod., January 1, 2005; 20(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G.M.G.J. Mulders, J. S.E. Laven, M. J.C. Eijkemans, F. H. de Jong, A. P.N. Themmen, and B. C.J.M. Fauser Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility Hum. Reprod., September 1, 2004; 19(9): 2036 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ng, C. C. W. Chan, W. S. B. Yeung, and P. C. Ho Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility Hum. Reprod., September 1, 2004; 19(9): 2132 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wallace and T. W. Kelsey Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography |